European Journal of Pharmaceutics and Biopharmaceutics
Impact Factor Trend (2018–2026)
Clarivate IF trend for European Journal of Pharmaceutics and Biopharmaceutics
SCImago Journal Rank citation prestige weighting
201 papers with at least that number of citations each
Aims & Scope
The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics. Topics covered include for example: Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids) Aspects of manufacturing process design Biomedical aspects of drug product design Strategies and formulations for controlled drug transport across biological barriers Physicochemical aspects of drug product development Novel excipients for drug product design Drug delivery and controlled release systems for systemic and local applications Nanomaterials for therapeutic and diagnostic purposes Advanced therapy medicinal products Medical devices supporting a distinct pharmacological effect.
Special Issues
Calls for Papers1 Calls for Papers · Automatically synced from ScienceDirect & publishers
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
PHARMACOLOGY & PHARMACY
PHARMACOLOGY & PHARMACY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisEuropean Journal of Pharmaceutics and Biopharmaceutics (acronym: ejpb, abbr: EUR. J. PHARM. BIOPHARM, ISSN: 0939-6411) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in Netherlands since 1991. The periodical holds a Journal Impact Factor (JIF) of 5.00, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 0.848 (Q1), an H-index of 201.
The journal enforces rigorous peer evaluation with an average review speed of 7.5周, a publication frequency of Bimonthly, an annual output of approximately 235 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,234 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics